1
by McDonagh, Marian S.
Published 2010
Oregon Health & Science University
... and agranulocytosis, differences among the drugs in other serious harms have not been clearly shown. Evidence on long...

2
by McDonagh, Marian S.
Published 2010
Oregon Health & Science University
... and agranulocytosis, differences among the drugs in other serious harms have not been clearly shown. Evidence on long...

3
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
..., but the difference was influenced by dose and resolved after 2 years of treatment. Atomoxetine caused similar...

4
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
..., but the difference was influenced by dose and resolved after 2 years of treatment. Atomoxetine caused similar...

5
by Smith, M. E. Beth
Published 2011
Oregon Health & Science University
... small sample size that was underpowered to detect a difference. Compared with placebo, duloxetine...

6
by Smith, M. E. Beth
Published 2011
Oregon Health & Science University
... small sample size that was underpowered to detect a difference. Compared with placebo, duloxetine...

7
by McDonagh, Marian S.
Published 2021
Agency for Healthcare Research and Quality
... was not significantly different between 2.5 mg and 5 mg dinoprostone gel, or latex and silicone single-balloon catheters...

8
by McDonagh, Marian S., Eden, Karen B., Peterson, Kim
Published 2005
Oregon Health & Science University
... are included in the same drug class, but have some differences in both mechanisms of action and side effects...

9
by McDonagh, Marian S., Eden, Karen B., Peterson, Kim
Published 2005
Oregon Health & Science University
... are included in the same drug class, but have some differences in both mechanisms of action and side effects...

10
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
... without relapse, over a 1 year period. Progression of disability was not different between the treatments...

11
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
... without relapse, over a 1 year period. Progression of disability was not different between the treatments...

12
by McDonagh, Marian S., Cantor, Amy, Bougatsos, Christina, Dana, Tracy
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
... for women and infants. One study reported no differences in maternal quality of life...

13
by McDonagh, Marian S., Cantor, Amy, Bougatsos, Christina, Dana, Tracy
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
... for women and infants. One study reported no differences in maternal quality of life...

14
by McDonagh, Marian S.
Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

15
by McDonagh, Marian S.
Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

16
by McDonagh, Marian S.
Published 2007
Oregon Health & Science University, Evidence-Based Practice Center
... of this review is to compare the effectiveness and safety of different disease-modifying drugs for the treatment...

17
by McDonagh, Marian S.
Published 2006
Oregon Health & Science University, Evidence-Based Practice Center
... of this review is to compare the benefits and harms of different PPIs...

18
by McDonagh, Marian S.
Published 2006
Oregon Health & Science University, Evidence-Based Practice Center
... of this review is to compare the benefits and harms of different PPIs...

19
by McDonagh, Marian S., Peterson, Kim, Dana, Tracy, Thakurta, Sujata
Published 2007
Oregon Health & Science University
... alternatives have been identified. The purpose of this review is to compare the benefits and harms of different...

20
by McDonagh, Marian S., Peterson, Kim, Dana, Tracy, Thakurta, Sujata
Published 2007
Oregon Health & Science University
... alternatives have been identified. The purpose of this review is to compare the benefits and harms of different...